90 related articles for article (PubMed ID: 15453960)
41. In vitro comparison of sestamibi, tetrofosmin, and furifosmin as agents for functional imaging of multidrug resistance in tumors.
Muzzammil T; Moore MJ; Ballinger JR
Cancer Biother Radiopharm; 2000 Aug; 15(4):339-46. PubMed ID: 11041018
[TBL] [Abstract][Full Text] [Related]
42. Reversal of P-glycoprotein-mediated multidrug resistance in human sarcoma MES-SA/Dx-5 cells by nonsteroidal anti-inflammatory drugs.
Angelini A; Iezzi M; Di Febbo C; Di Ilio C; Cuccurullo F; Porreca E
Oncol Rep; 2008 Oct; 20(4):731-5. PubMed ID: 18813811
[TBL] [Abstract][Full Text] [Related]
43. The effect of the plasticizer diethylhexyl phthalate on transport activity and expression of P-glycoprotein in parental and doxo-resistant human sarcoma cell lines.
Angelini A; Centurione L; Sancilio S; Castellani ML; Conti P; Di Ilio C; Porreca E; Cuccurullo F; Di Pietro R
J Biol Regul Homeost Agents; 2011; 25(2):203-11. PubMed ID: 21880209
[TBL] [Abstract][Full Text] [Related]
44. Doxorubicin selection for MDR1/P-glycoprotein reduces swelling-activated K+ and Cl- currents in MES-SA cells.
Luckie DB; Krouse ME; Law TC; Sikic BI; Wine JJ
Am J Physiol; 1996 Apr; 270(4 Pt 1):C1029-36. PubMed ID: 8928730
[TBL] [Abstract][Full Text] [Related]
45. Imaging multidrug resistance with radiolabeled substrates for P-glycoprotein and multidrug resistance protein.
Ballinger JR
Cancer Biother Radiopharm; 2001 Feb; 16(1):1-7. PubMed ID: 11279792
[No Abstract] [Full Text] [Related]
46. Comparative 99mTc-sestamibi and 3H-daunomycin uptake in human carcinoma cells: relation to the MDR phenotype and effects of reversing agents.
Cayre A; Moins N; Finat-Duclos F; Maublant J; Verrelle P
J Nucl Med; 1999 Apr; 40(4):672-6. PubMed ID: 10210228
[TBL] [Abstract][Full Text] [Related]
47. Quercetin-POM (pivaloxymethyl) conjugates: Modulatory activity for P-glycoprotein-based multidrug resistance.
Kim MK; Park KS; Choo H; Chong Y
Phytomedicine; 2015 Jul; 22(7-8):778-85. PubMed ID: 26141765
[TBL] [Abstract][Full Text] [Related]
48. Hibernoma: intense uptake seen on Tc-99m tetrofosmin and FDG positron emission tomographic scanning.
Chatterton BE; Mensforth D; Coventry BJ; Cohen P
Clin Nucl Med; 2002 May; 27(5):369-70. PubMed ID: 11953578
[No Abstract] [Full Text] [Related]
49. Reversal of multidrug resistance by methoxypolyethylene glycol-block-polycaprolactone diblock copolymers through the inhibition of P-glycoprotein function.
Elamanchili P; McEachern C; Burt H
J Pharm Sci; 2009 Mar; 98(3):945-58. PubMed ID: 18623213
[TBL] [Abstract][Full Text] [Related]
50. Malignant gliomas display altered plasma membrane potential and pH regulation--interaction with Tc-99m-MIBI and Tc-99m-Tetrofosmin uptakes.
Perek N; Denoyer D; Dubois F; Koumanov F
Gen Physiol Biophys; 2002 Dec; 21(4):381-404. PubMed ID: 12693711
[TBL] [Abstract][Full Text] [Related]
51. Pulsed exposure of SDZ PSC 833 to multidrug resistant P388/ADR and MCF7/ADR cells in the absence of anticancer drugs can fully restore sensitivity to doxorubicin.
Krishna R; de Jong G; Mayer LD
Anticancer Res; 1997; 17(5A):3329-34. PubMed ID: 9413167
[TBL] [Abstract][Full Text] [Related]
52. Technetium-99m-tetrofosmin, technetium-99m-MIBI and thallium-201 uptake in rat myocardial cells.
Arbab AS; Koizumi K; Toyama K; Arai T; Araki T
J Nucl Med; 1998 Feb; 39(2):266-71. PubMed ID: 9476934
[TBL] [Abstract][Full Text] [Related]
53. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K
Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833
[TBL] [Abstract][Full Text] [Related]
54. Paclitaxel-Based chemotherapy for non-small cell lung cancer: predicting the response with 99mTc-tetrofosmin chest imaging.
Kao CH; Hsieh JF; Tsai SC; Ho YJ; Changlai SP; Lee JK
J Nucl Med; 2001 Jan; 42(1):17-20. PubMed ID: 11197970
[TBL] [Abstract][Full Text] [Related]
55. Study of monoglutathionyl conjugates TC-99M-sestamibi and TC-99M-tetrofosmin transport mediated by the multidrug resistance-associated protein isoform 1 in glioma cells.
Le Jeune N; Perek N; Denoyer D; Dubois F
Cancer Biother Radiopharm; 2005 Jun; 20(3):249-59. PubMed ID: 15989470
[TBL] [Abstract][Full Text] [Related]
56. 99mTc-tetrofosmin for functional imaging of P-glycoprotein modulation in vivo.
Ballinger JR
J Clin Pharmacol; 2001 Jul; 41(S7):39S-47S. PubMed ID: 11452727
[TBL] [Abstract][Full Text] [Related]
57. Copper bis(diphosphine) complexes: radiopharmaceuticals for the detection of multi-drug resistance in tumours by PET.
Lewis JS; Dearling JL; Sosabowski JK; Zweit J; Carnochan P; Kelland LR; Coley HM; Blower PJ
Eur J Nucl Med; 2000 Jun; 27(6):638-46. PubMed ID: 10901449
[TBL] [Abstract][Full Text] [Related]
58. Different effects of magnetic field on drug activity in human uterine sarcoma cell lines MES-SA and MES-SA/Dx5.
Shibaki R; Kakikawa M
Electromagn Biol Med; 2022 Jul; 41(3):343-351. PubMed ID: 35793396
[TBL] [Abstract][Full Text] [Related]
59. Preliminary observations of malignant melanoma therapy using radiolabeled alpha-methyltyrosine.
McLaughlin WH; Thramann WM; Lambrecht RM; Milius RA; Bloomer WD
J Surg Oncol; 1988 Mar; 37(3):192-7. PubMed ID: 3352274
[TBL] [Abstract][Full Text] [Related]
60. Primary large cell neuroendocrine carcinoma: a cause of extracardiac uptake site of Tc99m tetrofosmin.
Atasever T; Vural G; Ayla K; Oztürk C
Semin Nucl Med; 1998 Apr; 28(2):196-7. PubMed ID: 9579423
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
